Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds (Q67364896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

title

Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

31 October 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

31 October 2023

author name string

J. A. Hickman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1212244

1 September 2022

D. H. Melzack

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1212244

1 September 2022

language of work or name

English

0 references

publication date

1 November 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

12 September 2019

https://api.elsevier.com/content/article/PII:0006295275903809?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

https://api.elsevier.com/content/article/PII:0006295275903809?httpAccept=text/plain

31 October 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

31 October 2023

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

page(s)

1947-1952

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.

12 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the walker tumour

31 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Studies on the reversal of the selective antitumour effect of the aziridinyl derivative cb 1954 by 4-amino-5-imidazolecarboxamide

31 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

31 October 2023

4

34

275

Mandel

1974

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

An extension of the 51Cr-release assay for the estimation of mouse cytotoxins

31 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

2-(4-chlorophenyl)thiazol-4-ylacetic acid('Myalex'): a new compound with anti-inflammatory,, analgesic and antipyretic activity

31 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Anti-inflammatory and antipyretic properties of N-(alpha,alpha,alpha-trifluoro-m-tolyl) anthranilic acid (CI-440; flufenamic acid)

31 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Ability of Some Antirheumatic Drugs to uncouple Oxidative Phosphorylation

31 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Prostaglandin Production by Experimental Tumours and Effects of Anti-inflammatory Compounds

31 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Tumour-growth inhibitorynitrofphenylaziridines and related compounds structure-activity relationships

31 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Chemical synthesis and biological activity of 8-substituted adenosine 3',5'-cyclic monophosphate derivatives

31 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Cyclophosphates VI. Cyclophosphates as substrates and effectors of phosphodiesterase

31 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Inhibition of cyclic 3′,5′-nucleotide phosphodiesterase—a possible mechanism of action of bifunctional alkylating agents

31 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

Protection against the toxicity of alkylating agents by thiols: The mechanism of protection and its relevance to cancer chemotherapy

31 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(75)90380-9

31 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1212244%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1 reference